Home/Filings/4/0001209191-19-017385
4//SEC Filing

FLAUM SANDER A 4

Accession 0001209191-19-017385

CIK 0000827871other

Filed

Mar 5, 7:00 PM ET

Accepted

Mar 6, 4:41 PM ET

Size

8.5 KB

Accession

0001209191-19-017385

Insider Transaction Report

Form 4
Period: 2019-03-05
Transactions
  • Exercise/Conversion

    Common Stock

    2019-03-05$4.04/sh+2,340$9,45413,714 total
  • Tax Payment

    Common Stock

    2019-03-05$48.89/sh204$9,97413,510 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2019-03-052,3400 total
    Exercise: $4.04Exp: 2019-03-06Common Stock (2,340 underlying)
Footnotes (2)
  • [F1]Represents shares withheld to satisfy the exercise price.
  • [F2]These shares are fully vested and immediately exercisable.

Issuer

EAGLE PHARMACEUTICALS, INC.

CIK 0000827871

Entity typeother

Related Parties

1
  • filerCIK 0001261026

Filing Metadata

Form type
4
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 4:41 PM ET
Size
8.5 KB